Dystrogen Therapeutics S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-02-19
Share capital
179,220.00 PLN
Activity description

Dystrogen Therapeutics is a clinical-stage biotechnology company developing chimeric cell therapy for muscle wasting disorders, especially Duchenne muscular dystrophy (DMD). It is testing DEC cell therapy, designed to work across DMD genetic mutations without immunosuppression. The company reports outcomes such as increased muscle force, reduced fatigue, and larger muscle fiber diameter and volume.

Registered address
ul. Kasztelańska 49, 60-316 Poznań, Poland
Email
Social media

Financials

This entity has not filed any financial documents with the Financial Document Repository (RDF).

Offer

Websites

  • dystrogen.comHome - Dystrogen Therapeutics Corporation
    WordPress 5.8ElementorGoogle AnalyticsGoogle Tag ManagerYoast SEOApache

Authorized Representatives

Manner of representation

Each member of the management board acting independently is authorized to make declarations of will on behalf of the company and to represent the company.

Supervisory board

Selvon St Clair – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2018-03-30 to 2024-06-14.

Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Feb 18, 2025Dissolution without liquidation opened
Nov 18, 2022Dissolution without liquidation opened
Sep 3, 2019Commercial Companies Code notice

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$4,622
Aid for SME access to finance — aid for start-ups
$381.2K

Competitors

Name
Famicordtx S.A.
Pharmena S.A.
VET Cell Tech sp. z o.o.
Vaxican sp. z o.o.
Personather sp. z o.o.
Biolabic sp. z o.o.
DR Joanna Sanford sp. k.
Cellis sp. z o.o.
Bioinfobank Capital sp. z o.o.
Synerga.Fund S.A.

Change history

DateEvent
2019-10-22Share capital increase
2018-02-19Entered in the register

FAQ

Last updated: 2026-03-29